Symptomatic response trajectories of etrasimod in UC patients: a post hoc analysis of the ELEVATE UC 52 trial - Sollacher, V; Woolcott, J C; Lees, C W; Jelinsky, S; Niezychowski, W; Schreiber, S (Zeitschrift für Gastroenterologie, 2025)